{"component": "definition", "props": {"groups": [{"size": 6, "snippet_links": [{"key": "cell-line", "type": "definition", "offset": [63, 72]}, {"key": "working-cell-bank", "type": "definition", "offset": [89, 106]}], "snippet": "means Client\u2019s reference deposit or collection of vials of the Cell Line, from which the Working Cell Bank is derived.", "samples": [{"hash": "cCqwDzsEOb5", "uri": "/contracts/cCqwDzsEOb5#master-cell-bank", "label": "Process Development and Manufacturing Services Agreement", "score": 31.3408622742, "published": true}, {"hash": "gddYnCdOCQ4", "uri": "/contracts/gddYnCdOCQ4#master-cell-bank", "label": "Process Development and Manufacturing Services Agreement (Bayhill Therapeutics, Inc.)", "score": 21.0, "published": true}], "hash": "ee9584f4429de498f8a5bcd6528b2aa6", "id": 1}, {"size": 4, "snippet_links": [], "snippet": "means [***].", "samples": [{"hash": "cHGagXi55FH", "uri": "/contracts/cHGagXi55FH#master-cell-bank", "label": "License Agreement (Mereo Biopharma Group PLC)", "score": 33.2436676025, "published": true}, {"hash": "atShSSjFV6t", "uri": "/contracts/atShSSjFV6t#master-cell-bank", "label": "Product Sublicense Agreement", "score": 31.3408622742, "published": true}, {"hash": "bC60BjUahoa", "uri": "/contracts/bC60BjUahoa#master-cell-bank", "label": "Product Sublicense Agreement (Immune Pharmaceuticals Inc)", "score": 25.7529087067, "published": true}], "hash": "42145ccc68badf480a8ed917c57dd5fc", "id": 2}, {"size": 4, "snippet_links": [{"key": "suspension-of", "type": "clause", "offset": [11, 24]}, {"key": "on-schedule", "type": "definition", "offset": [74, 85]}], "snippet": "means Cell Suspension of Urokinase Kidney Cells, Code 81987, as described on Schedule 2.1(c).", "samples": [{"hash": "lvRXvmTJJvm", "uri": "/contracts/lvRXvmTJJvm#master-cell-bank", "label": "Asset Purchase Agreement (Imarx Therapeutics Inc)", "score": 18.0, "published": true}, {"hash": "epL9jhYzp5W", "uri": "/contracts/epL9jhYzp5W#master-cell-bank", "label": "Asset Purchase Agreement (Imarx Therapeutics Inc)", "score": 18.0, "published": true}, {"hash": "6vGwIiAlNAG", "uri": "/contracts/6vGwIiAlNAG#master-cell-bank", "label": "Asset Purchase Agreement (Imarx Therapeutics Inc)", "score": 18.0, "published": true}], "hash": "32adf6872a67917eb00a4dcb54a37c4d", "id": 3}, {"size": 4, "snippet_links": [{"key": "product-cell-line", "type": "definition", "offset": [67, 84]}, {"key": "the-selected", "type": "clause", "offset": [115, 127]}, {"key": "single-cell", "type": "clause", "offset": [128, 139]}, {"key": "working-cell-banks", "type": "definition", "offset": [206, 224]}], "snippet": "or \u201cMCB\u201d means the reference deposit or collection of vials of the Product Cell Line, which has been prepared from the selected single cell clone under GMP conditions, and from which all subsequent lots of Working Cell Banks are derived.", "samples": [{"hash": "9F1R8UvWoIo", "uri": "/contracts/9F1R8UvWoIo#master-cell-bank", "label": "Option, Collaboration and License Agreement (BeiGene, Ltd.)", "score": 33.1587944031, "published": true}, {"hash": "gri9QZqrTrO", "uri": "/contracts/gri9QZqrTrO#master-cell-bank", "label": "Collaboration and License Agreement (BeiGene, Ltd.)", "score": 32.3429145813, "published": true}], "hash": "4ce3f34e2c64d710ecd87e217e7f432a", "id": 4}, {"size": 4, "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "cell-line", "type": "definition", "offset": [25, 34]}], "snippet": "means, with respect to a Cell Line, an aliquot of a single pool of cells of such Cell Line that has been prepared from a selected cell clone of such Cell Line under defined conditions, dispensed into multiple containers and stored under defined conditions.", "samples": [{"hash": "ej58nA8Xm0m", "uri": "/contracts/ej58nA8Xm0m#master-cell-bank", "label": "Strategic Collaboration and License Agreement (Adaptimmune Therapeutics PLC)", "score": 32.8412055969, "published": true}, {"hash": "jifmKZpDx5R", "uri": "https://www.adaptimmune.com/investors-and-media/sec-filings/all-sec-filings/content/0001558370-21-014594/0001558370-21-014594.pdf", "label": "www.adaptimmune.com", "score": 10.9206027985, "published": false}], "hash": "bc41829d50545b2ddcfa8d928347fa9c", "id": 5}, {"size": 3, "snippet_links": [{"key": "research-cell-bank", "type": "definition", "offset": [36, 54]}, {"key": "collaboration-product", "type": "clause", "offset": [61, 82]}, {"key": "requirements-for", "type": "clause", "offset": [110, 126]}, {"key": "cell-banks", "type": "clause", "offset": [127, 137]}, {"key": "the-production", "type": "clause", "offset": [146, 160]}, {"key": "biological-products", "type": "definition", "offset": [164, 183]}, {"key": "the-specifications", "type": "clause", "offset": [210, 228]}, {"key": "the-development-plan", "type": "clause", "offset": [254, 274]}, {"key": "a-portion", "type": "definition", "offset": [307, 316]}, {"key": "to-be-deposited", "type": "definition", "offset": [341, 356]}, {"key": "third-party-vendor", "type": "definition", "offset": [364, 382]}, {"key": "storage-and-preservation", "type": "clause", "offset": [387, 411]}, {"key": "working-cell-bank", "type": "definition", "offset": [472, 489]}], "snippet": "means a cell bank produced from the Research Cell Bank for a Collaboration Product that complies with (a) GMP requirements for cell banks used in the production of biological products for use in humans and (b) the specifications therefor as set forth in the Development Plan for such Collaboration Product, a portion of which is anticipated to be deposited with a Third Party vendor for storage and preservation and which cell bank may be used in the establishment of the Working Cell Bank for such Collaboration Product.", "samples": [{"hash": "1MWRLkuaoOQ", "uri": "/contracts/1MWRLkuaoOQ#master-cell-bank", "label": "Joint Development and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "j5UZifGUCDW", "uri": "/contracts/j5UZifGUCDW#master-cell-bank", "label": "Joint Development and License Agreement (Pfenex Inc.)", "score": 25.4791240692, "published": true}, {"hash": "fIzfWBeW6Gk", "uri": "/contracts/fIzfWBeW6Gk#master-cell-bank", "label": "Joint Development and License Agreement (Pfenex Inc.)", "score": 25.3394927979, "published": true}], "hash": "d7e5edc171ecfaf629ada66daa0074d0", "id": 6}, {"size": 3, "snippet_links": [{"key": "licensed-molecule", "type": "definition", "offset": [61, 78]}, {"key": "compliance-with-gmp", "type": "clause", "offset": [131, 150]}, {"key": "to-ensure", "type": "clause", "offset": [284, 293]}, {"key": "manufacturing-technology-transfer-plan", "type": "clause", "offset": [385, 423]}], "snippet": "means a culture of well characterized cells that express the Licensed Molecule which are derived from [***] cells, manufactured in compliance with GMP, adapted to a suitable medium composition, distributed into containers in a single operation, processed together in such a manner as to ensure uniformity, and stored in such a manner as to ensure stability as further described in the Manufacturing Technology Transfer Plan.", "samples": [{"hash": "eqpmmB0z0SJ", "uri": "/contracts/eqpmmB0z0SJ#master-cell-bank", "label": "License Agreement (RAPT Therapeutics, Inc.)", "score": 35.9760437012, "published": true}, {"hash": "f8P3dyXDGTA", "uri": "http://pdf.secdatabase.com/1014/0000950170-24-139667.pdf", "label": "pdf.secdatabase.com", "score": 19.8456497192, "published": false}, {"hash": "h3SaZrxFBKC", "uri": "https://investors.rapt.com/static-files/1474742f-041e-4487-9f24-eb9a675278c0", "label": "investors.rapt.com", "score": 19.7290534973, "published": false}], "hash": "76154c9f185f5b7f963041885d1e9c25", "id": 7}, {"size": 3, "snippet_links": [{"key": "e-coli", "type": "definition", "offset": [27, 34]}, {"key": "customer-supplied", "type": "clause", "offset": [88, 105]}], "snippet": "or \u201cMCB\u201d shall mean viable E. coli containing Parent Plasmid, transformed directly from CUSTOMER supplied stock under GMP conditions, diluted in glycerol and stored in sealed vials at less than minus sixty degrees Celsius.", "samples": [{"hash": "gXGCCt9P2sN", "uri": "/contracts/gXGCCt9P2sN#master-cell-bank", "label": "Master Product Sale Agreement (Biocancell Therapeutics Inc.)", "score": 21.0, "published": true}, {"hash": "cYyB9YWdB7H", "uri": "/contracts/cYyB9YWdB7H#master-cell-bank", "label": "Master Product Sale Agreement (Senesco Technologies Inc)", "score": 21.0, "published": true}, {"hash": "2REfVp6M970", "uri": "https://investors.eloxxpharma.com/static-files/32f8ebaa-8750-4d7d-932f-023c67ad1150", "label": "investors.eloxxpharma.com", "score": 9.9637231827, "published": false}], "hash": "ffb2ff43e301eb2cc7f0b1dcfe12ab27", "id": 8}, {"size": 3, "snippet_links": [{"key": "good-manufacturing-practices", "type": "clause", "offset": [8, 36]}, {"key": "research-cell-bank", "type": "definition", "offset": [111, 129]}, {"key": "to-ensure", "type": "clause", "offset": [266, 275]}], "snippet": "means a good manufacturing practices (GMP) manufactured culture of well characterized cells derived from VRC\u2019s Research Cell Bank, adapted to a suitable medium composition and distributed into containers in a single operation, processed together in such a manner as to ensure uniformity and stored in such a manner as to ensure stability.", "samples": [{"hash": "auAcKfKzcCs", "uri": "/contracts/auAcKfKzcCs#master-cell-bank", "label": "Biological Materials License Agreement", "score": 31.2899188995, "published": true}, {"hash": "isBRbhbiyPc", "uri": "/contracts/isBRbhbiyPc#master-cell-bank", "label": "Biological Materials License Agreement (HOOKIPA Pharma Inc.)", "score": 30.2183437347, "published": true}, {"hash": "hfxdkpIT5lH", "uri": "/contracts/hfxdkpIT5lH#master-cell-bank", "label": "Biological Materials License Agreement (HOOKIPA Pharma Inc.)", "score": 30.0431213379, "published": true}], "hash": "df7cbd146c238a769cff48311f618ec1", "id": 9}, {"size": 3, "snippet_links": [{"key": "cell-line", "type": "definition", "offset": [74, 83]}, {"key": "the-context", "type": "clause", "offset": [100, 111]}, {"key": "january-2004", "type": "clause", "offset": [169, 181]}, {"key": "working-cell-bank", "type": "definition", "offset": [208, 225]}, {"key": "manufacturing-process", "type": "definition", "offset": [288, 309]}], "snippet": "means Trubion's reference deposit or collection of vials from the related Cell Line, and refers, as the context requires, to (a) *** master cell bank constructed by *** January 2004 Agreement *** the related Working Cell Bank, *** establish seed cultures of the Cell Line to initiate the Manufacturing Process ***.", "samples": [{"hash": "fUpO1Ssg9V9", "uri": "/contracts/fUpO1Ssg9V9#master-cell-bank", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "hash": "90e462075e5f83c190970b1c394ba369", "id": 10}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIZbWFzdGVyLWNlbGwtYmFuayMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"size": 80, "snippet": "means Client\u2019s reference deposit or collection of vials of the Cell Line, from which the Working Cell Bank is derived.", "title": "Master Cell Bank", "id": "master-cell-bank", "examples": ["MPP shall ensure Afrigen will transfer to Spoke 2 vials of GMP <strong>Master Cell Bank</strong> (MCB) and, as soon as available, 10 vials of the GMP Working Cell Bank (WCB) of the Material in its possession; the aforementioned material can be used by Spoke for research and development and commercial purposes in the Commercial Territory with the granted rights provided in the Agreement.", "Likewise, iCo has brought to the attention of IMPH that in order for IMPH to make use of the <strong>Master Cell Bank</strong>, IMPH may need an agreement with Lonza.", "Limited Characterization of the cell bank for use in the production runs For the remaining 50 gram lots of L-DOS47 a <strong>Master Cell Bank</strong> (\u201cMCB\u201d) will be prepared and characterized.", "Drug Product: Storage temperatures between [**] Shipment temperatures between [**] Unformulated Drug Substance: Storage temperature at [**] <strong>Master Cell Bank</strong>: Stored in the [**].", "The ownership of the Back-up <strong>Master Cell Bank</strong> is transferred to Serendex.", "CBSB will prepare a Working Cell Bank for the recombinant strain from the existing <strong>Master Cell Bank</strong> provided by Tercica.", "Please note that if the request is for LiPSC- GR1.1 <strong>Master Cell Bank</strong> (GMP) materials, NHCDR may request proof of a pre-IND meeting with the FDA related to the SRI for which the cells are sought or evidence that the Principal Investigator has requested to reference the Master Drug File (MDF) for deposited LiPSC-GR1.1 <strong>Master Cell Bank</strong> (GMP) materials at the FDA.", "CBSB shall not use the Cell Line, <strong>Master Cell Bank</strong>, Working Cell Bank, Reference Material(s) and/or Null Plasmid Bank for any purpose except as authorized in writing by Tercica, and in no event shall CBSB modify or attempt to modify the Cell Line, <strong>Master Cell Bank</strong>, Working Cell Bank, Reference Material(s) and/or Null Plasmid Bank.", "Paragon shall not use any Cell Line, <strong>Master Cell Bank</strong>, or Working Cell Bank for any purpose except as authorized by this Agreement or authorized in writing by Client.", "Paragon shall maintain all portions of each Cell Line, <strong>Master Cell Bank</strong>, or Working Cell Bank that it receives from Client, Client\u2019s agents, or Paragon\u2019s Qualified Subcontractor, as the case may be, in safe and secure storage under its control in the Paragon Facility in accordance with the Storage Guidelines, and Paragon shall not transfer the Cell Line, <strong>Master Cell Bank</strong>, or Working Cell Bank to any Third Party that is not specifically authorized in advance and in writing by Client."], "related": [["shell-bank", "shell bank", "shell bank"], ["marijuana-processor", "Marijuana processor", "Marijuana processor"], ["master-batch-record", "Master Batch Record", "Master Batch Record"], ["large-facility-interconnection-procedures", "Large Facility Interconnection Procedures", "Large Facility Interconnection Procedures"], ["data-processing-agreement", "Data Processing Agreement", "Data Processing Agreement"]], "related_snippets": [], "updated": "2026-03-19T05:56:49+00:00"}, "json": true, "cursor": ""}}